These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 10516715
1. Retrovirus vectors designed for efficient transduction of cytotoxic or cytostatic genes. Ui M, Takada M, Arai T, Matsumoto K, Yamada K, Nakahata T, Nishiwaki T, Furukawa Y, Tokino T, Nakamura Y, Iba H. Gene Ther; 1999 Oct; 6(10):1670-8. PubMed ID: 10516715 [Abstract] [Full Text] [Related]
2. A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines. Arai T, Matsumoto K, Saitoh K, Ui M, Ito T, Murakami M, Kanegae Y, Saito I, Cosset FL, Takeuchi Y, Iba H. J Virol; 1998 Feb; 72(2):1115-21. PubMed ID: 9445007 [Abstract] [Full Text] [Related]
3. Dose-dependent transduction of vesicular stomatitis virus G protein-pseudotyped retrovirus vector into human solid tumor cell lines and murine fibroblasts. Arai T, Takada M, Ui M, Iba H. Virology; 1999 Jul 20; 260(1):109-15. PubMed ID: 10405362 [Abstract] [Full Text] [Related]
9. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines. Parker LP, Wolf JK, Price JE. Ann Clin Lab Sci; 2000 Oct 20; 30(4):395-405. PubMed ID: 11045764 [Abstract] [Full Text] [Related]
10. Safe and efficient ecotropic and amphotropic packaging lines for use in gene transfer experiments. Markowitz DG, Goff SP, Bank A. Trans Assoc Am Physicians; 1988 Oct 20; 101():212-8. PubMed ID: 3077729 [Abstract] [Full Text] [Related]
11. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment. Qiao J, Moreno J, Sanchez-Perez L, Kottke T, Thompson J, Caruso M, Diaz RM, Vile R. Gene Ther; 2006 Oct 20; 13(20):1457-70. PubMed ID: 16724095 [Abstract] [Full Text] [Related]
12. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer. Kijima T, Osaki T, Nishino K, Kumagai T, Funakoshi T, Goto H, Tachibana I, Tanio Y, Kishimoto T. Cancer Res; 1999 Oct 01; 59(19):4906-11. PubMed ID: 10519403 [Abstract] [Full Text] [Related]
13. Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53. Kichina JV, Rauth S, Das Gupta TK, Gudkov AV. Oncogene; 2003 Jul 31; 22(31):4911-7. PubMed ID: 12894234 [Abstract] [Full Text] [Related]
14. Development and characterization of an antisense-mediated prepackaging cell line for adeno-associated virus vector production. Okada T, Mizukami H, Urabe M, Nomoto T, Matsushita T, Hanazono Y, Kume A, Tobita K, Ozawa K. Biochem Biophys Res Commun; 2001 Oct 19; 288(1):62-8. PubMed ID: 11594752 [Abstract] [Full Text] [Related]
15. [Construction of the wt-p53 gene recombinant retroviral vector. Inhibiting the growth of laryngocarcinoma cell line]. Chen X, Cao K, Liu D, Wang Z, Liang C. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Aug 19; 18(4):252-6. PubMed ID: 9388972 [Abstract] [Full Text] [Related]
16. Adenovirus-mediated Bak gene transfer induces apoptosis in mesothelioma cell lines. Pataer A, Smythe WR, Yu R, Fang B, McDonnell T, Roth JA, Swisher SG. J Thorac Cardiovasc Surg; 2001 Jan 19; 121(1):61-7. PubMed ID: 11135160 [Abstract] [Full Text] [Related]
17. In vivo gene marking of rhesus macaque long-term repopulating hematopoietic cells using a VSV-G pseudotyped versus amphotropic oncoretroviral vector. Shi PA, De Angioletti M, Donahue RE, Notaro R, Luzzatto L, Dunbar CE. J Gene Med; 2004 Apr 19; 6(4):367-73. PubMed ID: 15079811 [Abstract] [Full Text] [Related]
18. Retrovirus vector containing wild type p53 gene and its effect on human glioma cells. Hlavatý J, Tyukosova S, Bies J, Hlubinova K, Altaner C. Neoplasma; 2000 Apr 19; 47(4):204-11. PubMed ID: 11043823 [Abstract] [Full Text] [Related]
19. Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors. Sparacio S, Pfeiffer T, Schaal H, Bosch V. Mol Ther; 2001 Apr 19; 3(4):602-12. PubMed ID: 11319923 [Abstract] [Full Text] [Related]
20. Production of retrovirus and adenovirus vectors for gene therapy: a comparative study using microcarrier and stationary cell culture. Wu SC, Huang GY, Liu JH. Biotechnol Prog; 2002 Apr 19; 18(3):617-22. PubMed ID: 12052081 [Abstract] [Full Text] [Related] Page: [Next] [New Search]